Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)

NCT01078545 · clinicaltrials.gov ↗

COMPLETED

Status

729

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Prostate Cancer
Lower Urinary Tract Symptoms

Interventions

DRUG: Leuprolide acetate Depot Susp. 11.25 mg (Poland), 3.75 mg (Ukraine)

Sponsor

Abbott

Collaborators

[object Object]
[object Object]